Crista Galli Ventures is a healthtech fund investing in ambitious European healthtech companies at Seed and Series A. Their deep medical expertise, powerful network, and agile approach enable founders to build important, world-class healthcare businesses. They are focused on a patient-centric future, powered by healthcare data and transformed by technology, including deep tech, digital health, and personalized healthcare.

Fiona Pathiraja

Crista Galli Ventures

Healthtech fund. We are the healthtech arm of the Family Office of Dr Fiona Pathiraja & Søren Fryland Møller 🇬🇧🇩🇰

Metric
Company Name	Crista Galli Ventures
Symbol
MSH ID	COM:CRISTAGALLI
Market	PRIVATE
Sector	Investment Management
Industry	Healthcare, Healthtech, Venture Capital
Country	GB
Stage
Employee Count	2
Website	cristagalli.com
LinkedIn	crista-galli-ventures
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	88
Web Traffic Growth	0.04
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:CRISTAGALLI

Crista Galli Ventures

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue